346735-24-8
![346735-24-8 结构式](/CAS/20200611/GIF/346735-24-8.gif)
基本信息
英文别名
BIIL 284Amelubant
Amelubant (BIIL284
Carbamic acid, N-[[4-[[3-[[4-[1-(4-hydroxyphenyl)-1-methylethyl]phenoxy]methyl]phenyl]methoxy]phenyl]iminomethyl]-, ethyl ester
常见问题列表
生物活性
Amelubant (BIIL 284) 是一种有效、可口服、长效的 LTB4 receptor 拮抗剂,对 LTB4 受体的结合亲和性很低,在细胞和细胞膜中,Ki 值分别为 221 nM 和 230 nM。Amelubant (BIIL 284) 是活性代谢物 BIIL 260 和 BIIL 315 的前体。具有抗炎活性。靶点
LTB 4 221 nM (Ki, in vital human granulocytes) |
LTB 4 230 nM (Ki, in cell membranes) |
体外研究
Amelubant is a prodrug of active metabolites BIIL 260 and BIIL 315, which are reversible and competitive LTB 4 receptor antagonists, with K i s of 1.4, 1.1 nM and 1.7, 1.9 nM in vital cells and membranes, respectively.